Results 271 to 280 of about 299,961 (316)
Some of the next articles are maybe not open access.

Cyclin D1 as a target for chemoprevention

Lung Cancer, 2003
Lung cancer is the leading cause of cancer mortality. Chemoprevention is an attractive strategy to combat this major public health problem. Pre-clinical and clinical studies have identified diverse candidate chemopreventive agents that affect cellular proliferation, differentiation, apoptosis and tumor angiogenesis, among other pathways.
W Jeffrey, Petty   +2 more
openaire   +2 more sources

Cyclin D1 Immunoreactivity in Meningiomas

Cellular and Molecular Neurobiology, 2008
Cyclin D1 is an important nuclear protein required for progression of cells through the G1 phase of the cell cycle. The proliferative potential of meningiomas has been studied using various proliferative markers. However, there have been only few published studies evaluating Cyclin D1 immunoreactivity in meningiomas.The aim of our study was to analyze ...
Sanja, Milenković   +5 more
openaire   +2 more sources

Cyclin D1 in mammary carcinoma

The Journal of Pathology, 1997
The control of the cell-cycle-associated protein cyclin D1 and its variable behaviour in normal and transformed cells is described and contrasted with its activity in vivo. The role of cyclin D1 as a prognostic and predictive marker is examined in clinical breast cancer.
openaire   +2 more sources

The activities of cyclin D1 that drive tumorigenesis

Trends in Molecular Medicine, 2004
The proto-oncogene cyclin D1 has been implicated in the genesis of a large proportion of human tumors from diverse histological origins. It has long been assumed that the action of cyclin D1, as an activator of cdk4 and cdk6 and leading to progression through the G1 phase of the cell cycle, underlies its pathological activity.
Mark E, Ewen, Justin, Lamb
openaire   +2 more sources

Cyclin D1 overexpression in hepatocellular carcinoma

Liver, 2001
Abstract: Background/Aims: Cyclin D1 gene amplification and cyclin D1 protein overexpression have been reported in various human tumors, including hepatocellular carcinoma (HCC). However, their significance is still controversial. In the present study, we examined the expression of cyclin D1 and its relationships to p53 and Ki‐67 in HCCs. Methods: The
M, Joo   +4 more
openaire   +2 more sources

Cyclin D1 positive follicular lymphoma

Journal of Clinical Pathology, 2009
This report describes an unusual case of cyclin D1 expression by an otherwise typical follicular lymphoma, of low histological grade. BCL2–IGH and CCND1–IGH fusions were identified by interphase fluorescence in situ hybridisation.
B, Olsen   +4 more
openaire   +2 more sources

Cyclin D1 in Breast Cancer Pathogenesis

Journal of Clinical Oncology, 2005
Taking a perspective on available evidence that emphasizes relevance to human disease, cyclin D1 is solidly established as an oncogene with an important pathogenetic role in breast cancer and other human tumors. However, the precise cellular mechanisms through which aberrant cyclin D1 expression drives human neoplasia are less well established. Indeed,
Andrew, Arnold, Alexandros, Papanikolaou
openaire   +2 more sources

Regulation of cyclin D1 gene expression

Biochemical Society Transactions, 2010
Cyclin D1 is a key regulator of cell proliferation and its expression is subject to both transcriptional and post-transcriptional regulation. In different cellular contexts, different pathways assume a dominant role in regulating its expression, whereas their disregulation can contribute to overexpression of cyclin D1 in tumorigenesis. Here, we discuss
Ini-Isabée, Witzel   +2 more
openaire   +2 more sources

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors

Science China Life Sciences, 2022
Zijie Cai   +16 more
semanticscholar   +1 more source

Implication of Cyclin D1 in Malignant Lymphoma

Critical Reviews™ in Oncogenesis, 1996
The chromosomal translocation t(11;14)(q13;q32) is observed in a number of lymphoid malignancies but is specifically associated with a particular subtype of non-Hodgkin's lymphoma called mantle cell lymphoma, where it is observed in up to 70% of cases. This translocation juxtaposes IGH sequences at 14q32 to a region variously termed BCL1/PRAD1 at 11q13,
M, Callanan   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy